Alpha Teknova (NASDAQ:TKNO) Shares Down 1.3% – Here’s What Happened

Shares of Alpha Teknova, Inc. (NASDAQ:TKNO) traded down 1.3% on Friday . The stock traded as low as $4.61 and last traded at $4.69. 71,686 shares changed hands during trading, a decline of 64% from the average session volume of 197,372 shares. The stock had previously closed at $4.75.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Alpha Teknova in a report on Wednesday, October 8th. One research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $10.00.

Alpha Teknova Stock Performance

The company has a debt-to-equity ratio of 0.18, a current ratio of 5.27 and a quick ratio of 4.27. The company has a market cap of $251.05 million, a price-to-earnings ratio of -13.40 and a beta of 0.39. The firm has a 50 day simple moving average of $5.15 and a 200-day simple moving average of $5.08.

Alpha Teknova (NASDAQ:TKNO) last issued its quarterly earnings data on Thursday, November 6th. The company reported ($0.08) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.09) by $0.01. Alpha Teknova had a negative net margin of 45.78% and a negative return on equity of 23.53%. The firm had revenue of $10.45 million for the quarter, compared to analyst estimates of $10.23 million. Alpha Teknova has set its FY 2025 guidance at EPS. As a group, analysts predict that Alpha Teknova, Inc. will post -0.58 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of TKNO. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new position in Alpha Teknova in the second quarter worth approximately $29,000. JPMorgan Chase & Co. increased its position in shares of Alpha Teknova by 123.1% in the 2nd quarter. JPMorgan Chase & Co. now owns 8,163 shares of the company’s stock valued at $40,000 after purchasing an additional 4,504 shares during the last quarter. Larson Financial Group LLC raised its holdings in shares of Alpha Teknova by 58.5% in the 3rd quarter. Larson Financial Group LLC now owns 9,387 shares of the company’s stock valued at $58,000 after purchasing an additional 3,464 shares in the last quarter. McAdam LLC purchased a new stake in shares of Alpha Teknova during the 1st quarter worth $60,000. Finally, Whalen Wealth Management Inc. purchased a new stake in shares of Alpha Teknova during the 3rd quarter worth $77,000. 13.81% of the stock is owned by institutional investors and hedge funds.

Alpha Teknova Company Profile

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.